HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sally Beauty Acquisitions To Push Sally Sales Over $200 Mil. In Next 12 Mos.

This article was originally published in The Rose Sheet

Executive Summary

Alberto-Culver's Sally Beauty Systems Group completed the acquisition of two full-service beauty supply distributors for $20 mil., the company announced Jan. 27. Alberto said it will continue "to search for promising acquisition candidates."

You may also be interested in...



Sally Beauty

Beauty Systems Group subsidiary acquires full-service distributor Macon Beauty Supply, Alberto-Culver announces Jan. 28. Macon, which has annual sales of $40 mil., employs a sales force of 70 and operates 22 professional retail stores. Macon distributes the Matrix, L'Oreal, Graham Webb, OPI and Creative Nail brands in southern states, including Georgia, Florida and the Carolinas. The purchase is expected to increase Beauty Systems' sales to $300 mil. The company completed the purchase of two smaller full-service chains - G.A. Kayser & Sons and United/Ace Beauty Supply - in early 1999 (1"The Rose Sheet" Feb. 1, 1999, p. 18). Alberto is considering other acquisitions for the company

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006261

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel